Company / Free Cash Flow per Share
Co-Diagnostics, Inc. Free Cash Flow per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$27.08
FY2025
5-year range
-$27.08 / $1.19
FY2021-FY2025
Trend
-2730.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share changed -2731% YoY in FY2025, a notable deviation from the 8-year average annual change of -328%.
Based on SEC 10-K filings.
-27.08 in FY2025.
Declined from $-0.76 to $-27.08 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Co-Diagnostics, Inc.'s free cash flow per share has declined for 3 consecutive years.
- In FY2025, free cash flow per share decreased 2730.9% year-over-year.
- Peak free cash flow per share was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$27.08 | -2730.9% |
| FY2024 | -$0.96 | -26.0% |
| FY2023 | -$0.76 | -163.6% |
| FY2022 | $1.19 | +24.6% |
| FY2021 | $0.96 | +395.0% |
| FY2020 | -$0.33 | -1.9% |
| FY2019 | -$0.32 | -17.6% |
| FY2018 | -$0.27 | -102.4% |
| FY2017 | -$0.13 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026